MYLAN 7150 MYLAN 7150 Pill - blue capsule/oblong
Pill with imprint MYLAN 7150 MYLAN 7150 is Blue, Capsule/Oblong and has been identified as Celecoxib 200 mg. It is supplied by Mylan Institutional Inc.
Celecoxib is used in the treatment of Ankylosing Spondylitis; Osteoarthritis; Chronic Pain; Juvenile Rheumatoid Arthritis; Familial Adenomatous Polyposis and belongs to the drug class cox-2 inhibitors. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celecoxib 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 7150 MYLAN 7150

Celecoxib
- Imprint
- MYLAN 7150 MYLAN 7150
- Strength
- 200 mg
- Color
- Blue
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Cox-2 inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Institutional Inc.
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
sodium lauryl sulfate,
titanium dioxide,
FD&C Blue No. 1,
FD&C Red No. 3,
ferrosoferric oxide,
D&C Yellow No. 10,
FD&C Blue No. 2,
FD&C Red No. 40,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00378-7150 (Discontinued) | Mylan Pharmaceuticals Inc. |
51079-0215 (Discontinued) | UDL Laboratories Inc. |
More about celecoxib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (280)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: cox-2 inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.